Time to Reconsider Incyte Genomics Incorporated (NASDAQ:INCY) After More Short Sellers?

Lloyd Doyle
December 15, 2017

The stock decreased 0.15% or $0.03 during the last trading session, reaching $20.52. About 981,592 shares traded. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since December 14, 2016 and is uptrending. It has underperformed by 23.76% the S&P500. Mirae Asset Global Investments acquired 3,670 shares as Marriott Intl Inc New (MAR)'s stock rose 15.06%. The stock increased 0.53% or $0.115 during the last trading session, reaching $21.925. IFP Advisors Inc now owns 1,146 shares of the biopharmaceutical company's stock valued at $144,000 after purchasing an additional 103 shares during the period. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since December 14, 2016 and is uptrending. It has outperformed by 56.14% the S&P500.

Investors sentiment decreased to 1.02 in Q2 2017. During the same period last year, the firm earned $0.19 EPS. equities analysts anticipate that Incyte Corporation will post -1.33 EPS for the current year. 195.76 million shares or 16.43% more from 168.14 million shares in 2017Q1 were reported. 83 are owned by Mark Sheptoff Planning Limited Liability Company. Maryland-based Brown Advisory has invested 0% in StoneCastle Financial Corp. Hsbc Public Llc reported 131,457 shares. Capital Ltd Ca owns 492,416 shares. Glenmede Trust Na owns 670 shares for 0% of their portfolio. United Cap Finance Advisers Limited Liability Company invested in 0% or 1,623 shares. Huntington Bancorp holds 300 shares. Tealwood Asset reported 9,956 shares. Fund holds 9,828 shares or 0.01% of its portfolio. The Davide Leone & Partners Investment Company Llp holds 412,100 shares with $51.89 million value, up from 278,100 last quarter. Kentucky Retirement accumulated 10,895 shares or 0.1% of the stock. Sei Investments Co. increased its holdings in shares of Incyte by 60.6% during the 2nd quarter. Verisign Inc (NASDAQ:VRSN) was reduced too. Tharby Linda M sold $941,254 worth of stock or 4,695 shares. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. The insider Mas Ribo Alberto sold 7,463 shares worth $1.50 million. Analysts have a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Therefore 53% are positive. On Tuesday, October 17 the stock rating was maintained by SunTrust with "Hold". The rating was maintained by Oppenheimer with "Outperform" on Monday, November 9. The firm has "Market Perform" rating by Cowen & Co given on Friday, November 13. RBC Capital Markets has "Buy" rating and $26.0 target. Tower Research Capital LLC TRC now owns 891 shares of the biopharmaceutical company's stock valued at $112,000 after acquiring an additional 108 shares in the last quarter. The firm has "Buy" rating by Jefferies given on Tuesday, June 20. $2.80 million worth of Incyte Corporation (NASDAQ:INCY) was sold by SWAIN PAULA J on Thursday, August 31. Therefore 55% are positive. Incyte had 73 analyst reports since August 6, 2015 according to SRatingsIntel. Credit Suisse initiated the stock with "Outperform" rating in Monday, January 23 report. The company was maintained on Monday, October 2 by Canaccord Genuity. On Tuesday, January 5 the stock rating was initiated by Raymond James with "Mkt Perform". Flannelly Barry P sold $88,715 worth of stock.

University Of Notre Dame Du Lac increased Incyte Corp (INCY) stake by 12.26% reported in 2017Q2 SEC filing. BMO Capital Markets maintained Incyte Corporation (NASDAQ:INCY) on Thursday, October 12 with "Buy" rating. As per Tuesday, August 18, the company rating was downgraded by Vetr.

Since August 1, 2017, it had 1 insider purchase, and 8 insider sales for $342,984 activity. The stock of Incyte Corporation (NASDAQ:INCY) earned "Buy" rating by Argus Research on Tuesday, August 18. Another trade for 1,820 shares valued at $241,914 was sold by Siegel Eric H. Jefferies Group LLC reiterated a buy rating and issued a $148.00 target price on shares of Incyte Corporation in a report on Thursday, May 18th. BAKER BROS. ADVISORS LP had bought 100,000 shares worth $13.20M on Friday, September 8. Its down 0.26, from 1.11 in 2017Q1. It fall, as 57 investors sold INCY shares while 158 reduced holdings. Vanguard Group Inc. raised its stake in Incyte by 11.1% during the 2nd quarter. After $0.17 actual earnings per share reported by Incyte Corporation for the previous quarter, Wall Street now forecasts -376.47% negative EPS growth. Arrowstreet Cap Ltd Partnership holds 18,200 shares. Northern Corp holds 0% or 12,870 shares. The stock of Incyte Corporation (NASDAQ:INCY) earned "Overweight" rating by Barclays Capital on Friday, April 7. Incyte Corporation (NASDAQ:INCY) last released its quarterly earnings data on Thursday, May 4th. France-based Natixis Asset has invested 0.08% in Incyte Corporation (NASDAQ:INCY). The New York-based Oppenheimer has invested 0.02% in StoneCastle Financial Corp. Kistler owns 50 shares. Eqis Mngmt stated it has 0.14% in Incyte Corporation (NASDAQ:INCY). Dynamic Capital Mgmt Limited has 4,650 shares for 0.13% of their portfolio. Oppenheimer maintained Incyte Corporation (NASDAQ:INCY) on Monday, November 9 with "Outperform" rating. Lord Abbett And Lc accumulated 457,455 shares.

Receive News & Ratings for Incyte Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incyte Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article